Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Type 2 DNA topoisomerase 6 subunit B-like (TOP6BL) is a component of the topoisomerase VI-like complex that is specifically required for the initiation of meiotic DNA double-strand breaks (DSBs), which are essential for homologous recombination, accurate chromosome pairing, and segregation during meiosis[1][2][3][4]. TOP6BL is the eukaryotic homolog of the archaeal Top6B subunit and forms a holocomplex with SPO11, enabling SPO11's endonucleolytic activity to generate DSBs in meiotic cells[2][3]. Loss of TOP6BL or its partner SPO11 results in meiotic arrest and infertility in mammals[2]. While TOP6BL is structurally related to classical type IIB topoisomerases, its physiological role is distinct and specialized for meiosis; it is not known to be a therapeutic or drug target[2][3][4]. No interacting drugs or clinical biomarkers are reported for TOP6BL at present[4]. Defects or loss of function in this complex are associated primarily with infertility due to failure of meiotic recombination rather than with cancer or other somatic diseases[2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Type 2 DNA topoisomerase 6 subunit B-like (TOP6BL).